hMATE1 (SLC47A1)

The human multidrug and toxin extrusion transporter 1 (hMATE1; SLC47A1) is highly expressed on the apical side of renal proximal and distal tubule cells and on the canalicular membrane of hepatocytes. There MATE1 is acting as electroneutral exchanger of its substrates with oppositely directed proton gradient as a driving force. Although export is the presumed physiological role, depending on the intracellular and extracellular pH, MATEs may also act as an uptake transporter. Typical substrates for MATEs are hydrophilic, low-molecular-weight organic cations such as metformin and 1-methy-4-phenylpyridinium (MPP).

Main localization:
Liver, kidney
Transporter assay:
Uptake transporter assay (potential substrate and inhibitor)
Probe substrates:
Metformin, 1-methyl-4-phenyl-pyridinium (MPP)
Probe inhibitors:
Cimetidine, ketoconazole
Regulatory relevance:
FDA guidance, EMA considered
Important interacting drugs:
Cimetidine, metformin, topotecan, cetirizine, mitoxantrone, procainamide, quinidine, ranitidine, ritonavir, verapamil, ketoconazole
From other species:
mMate1


Inhibition of hMATE1-mediated metformin uptake by different inhibitors (100 µM)
Home | Services | Drug Transporter Assays | Drug Transporter | About us | News and Events | Contact | Imprint | Privacy Policy


PortaCellTec Biosciences GmbH • Weender Landstraße 94-108 • 37075 Göttingen • Germany • T. 0049 551 309 66440 • F. 0049 551 309 66442 •
info@portacelltec.de • © PortaCellTec Biosciences 2018